Shiley 3.0PED Cuffless Pediatric Tracheostomy Tube by Covidien Inc. Class 1 Recall due to complaints received about difficulty inserting the device used to place the tracheostomy tube into the windpipe (obturator), and/or a suction tube (catheter) into the tracheostomy tube.
Source: www.fda.govInnocoll Announces Dosing Of Last Patient In Second US Phase 3 Clinical Trial To Investigate GENTAMICIN SURGICAL IMPLANT For Prevention Of Infections Innocoll, Inc., a privately-held biopharmaceutical company, announced that the last patient has been dosed in the second of two ongoing U.S. phase 3 clinical trials sponsored by its wholly owned subsidiary, Innocoll Technologies Ltd, to investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the prevention of surgical site infections. The trial is being conducted at approximately 45 hospital sites across the U.S.
Source: www.medicalnewstoday.comVaccine Against CMV Shows Promise In Clinical Trial A new vaccine has the potential to be the first to prevent maternal and congenital cytomegalovirus (CMV) infection, according to a University of Alabama at Birmingham (UAB) study published in the March 19 edition of the New England Journal of Medicine.
Source: www.medicalnewstoday.comMetoclopramide-Containing Drugs Chronic use of metoclopramide has been linked to tardive dyskinesia, which may include involuntary and repetitive movements of the body, even after the drugs are no longer taken.
Source: www.fda.govMarch 2009 Patient Safety News Video news show for healthcare professionals, covering safety alerts, recalls, product approvals, and important tips on protecting patients.
Source: www.fda.govNerves At The Ventral Prostatic Capsule Contribute To Erectile Function: Initial Electrophysiological Assessment In Humans UroToday.com - When performing nerve sparing radical prostatectomy, how high up on the lateral prostatic fascia do urologists need to go to release the neurovascular bundle (NVB)? Are there even functional nerve fibers higher than the main bundle located at the 5 o'clock position? This question is answered by Dr. Yasuhiro Kaiho and colleagues at Tohoku University in an online report that appeared in European Urology.
Source: www.medicalnewstoday.comUnique Nerve-Stimulation Device Proves Effective Against Epilepsy Epilepsy is a common medical condition characterized by convulsions and short periods of confusion. It affects more than 50 million people worldwide. But intractable epilepsy, which affects more than 1 million Americans and is often resistant to drug treatment and surgery, is arguably worse. But in a just completed clinical trial, a unique nerve-stimulation treatment for intractable epilepsy reduced the number of seizures by more than 50 percent.
Source: www.medicalnewstoday.com
# posted by Network @ 5:10 PM
